• By ICR Secretariat
  • Posted Thursday, June 10, 2021

MHRA authorises Pfizer/BioNTech’s COVID-19 vaccine for 12- to 15-year-olds

http://www.pharmatimes.com/news/mhra_authorises_pfizerbiontechs_covid-19_vaccine_for_12-_to_15-year-olds_1371273

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has extended the authorisation of Pfizer/BioNTech’s COVID-19 vaccine for use in children aged 12 to 15 years old.